197 results
424B3
SNGX
Soligenix Inc
10 May 24
Prospectus supplement
4:16pm
entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers … such contingent liabilities, and such assessment inherently involves an exercise of judgment. A liability is only recorded if management determines
424B4
SNGX
Soligenix Inc
19 Apr 24
Prospectus supplement with pricing info
4:05pm
in the first successful Phase 3 FLASH study that consisted of three 6-week treatment cycles (18 weeks total), with the primary efficacy assessment occurring … -controlled assessment to 18 weeks of continuous treatment (no “between-Cycle” treatment breaks) with the primary endpoint assessment occurring
8-K
EX-99.2
ezu4 c6ei4u6mtixv
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
EX-99.1
hzvaoj7ph04ug0cfs5
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
EX-99.1
8fn vjl91jp4o3m
19 Dec 22
Other Events
8:00am